{"id":411819,"title":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-25","captureTimestamp":"2026-01-25T01:56:13.480000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html","snippet":"Consultation of Draft Guidance Documents: Identifying and Labelling Medicinal Ingredients, Generic Drug Equivalence: Medicinal Ingredients Current status: Closed This consultation ran from April 8, 2019 to June 17, 2019. Health Canada is proposing amendments to the Food and Drug…","rawSnapshotUrl":"/api/snapshots/raw/411819","browseUrl":"https://replay.healtharchive.ca/job-6/20260125015613/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence.html#ha_snapshot=411819","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}